AMARIN CORP PLC\UK Payments to Acquire Long-term Investments
AMARIN CORP PLC\UK (AMRN) reported Payments to Acquire Long-term Investments of $1.65 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLongtermInvestments · last filed 2015-03-03
- AMARIN CORP PLC\UK payments to acquire long-term investments for the quarter ending 2012-12-31 was $412.00K.
- AMARIN CORP PLC\UK payments to acquire long-term investments for the quarter ending 2012-09-30 was $413.00K.
- AMARIN CORP PLC\UK payments to acquire long-term investments for the quarter ending 2011-12-31 was $0.00.
- AMARIN CORP PLC\UK payments to acquire long-term investments for fiscal 2012 was $1.65M, a 0.00% change from fiscal 2011.
- AMARIN CORP PLC\UK payments to acquire long-term investments for fiscal 2011 was $1.65M.
| Period end | Payments to Acquire Long-term Investments 3 month | Payments to Acquire Long-term Investments 6 month | Payments to Acquire Long-term Investments 9 month | Payments to Acquire Long-term Investments 12 month |
|---|---|---|---|---|
| 2012-12-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $825.00K derived: sum of 2 quarters · filed 2015-03-03 | $1.65M 10-K · filed 2015-03-03 | |
| 2012-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.24M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $825.00K 10-Q · filed 2013-08-08 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $1.65M 10-K · filed 2014-02-27 | ||
| 2011-09-30 | $1.65M 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |